Cargando…
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
A more common and noninvasive predicting biomarker for programmed cell death 1 (PD-1) antibody remains to be explored. We assessed 46 patients with advanced gastric cancer who received PD-1 antibody immunotherapy and 425-genes next-generation sequencing (NGS) testing. Patients who had a > 25% dec...
Autores principales: | Jin, Ying, Chen, Dong-Liang, Wang, Feng, Yang, Chao-pin, Chen, Xu-Xian, You, Jin-qi, Huang, Jin-Sheng, Shao, Yang, Zhu, Dong-Qin, Ouyang, Yu-Ming, Luo, Hui-Yan, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Xu, Rui-Hua, Zhang, Dong-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596978/ https://www.ncbi.nlm.nih.gov/pubmed/33126883 http://dx.doi.org/10.1186/s12943-020-01274-7 |
Ejemplares similares
-
Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms
por: Wang, Zi-Xian, et al.
Publicado: (2016) -
The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis
por: Wang, Zi-Xian, et al.
Publicado: (2016) -
The Role of Non-Curative Surgery in Incurable, Asymptomatic Advanced Gastric Cancer
por: He, Ming-ming, et al.
Publicado: (2013) -
Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
por: Jin, Ying, et al.
Publicado: (2013) -
Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer
por: He, Ming‐ming, et al.
Publicado: (2018)